on 26 Jul 2022
Last Applicant/ Owned by
155 Franklin Road, Suite 450
Brentwood
TN
37027
Serial Number
88404065 filed on 26th Apr 2019
Registration Number
6804470 registered on 26th Jul 2022
Correspondent Address
Andrew N. Spivak
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"PHARMACEUTICALS LLC"
The mark consists of The large word "CURRAX" with a capital "C" evenly-spaced directly above the smaller, lowercase words "PHARMACEUTICAL LLC". Under "PHARMACEUTICALS LLC" is a thin line, and above the letter "X" in "CURRAX" are two stacked, overlapping diamond shapes. Pharmaceutical preparations for use in connection with humans for treatment of disorders, diseases and conditions of the endocrinRead More
Pharmaceutical preparations for use in connection with humans for treatment of disorders, diseases and conditions of the endocrinology, cardiology, neurology, gastroenterology, pulmonary, and immune systems and for treatment of metabolic and psychiatric disorders, diseases and conditions
15th Apr 2019
01st May 2019
No 88404065
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.07.14 -
Three diamonds
26.07.21 -
Diamonds that are completely or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
The mark consists of The large word "CURRAX" with a capital "C" evenly-spaced directly above the smaller, lowercase words "PHARMACEUTICAL LLC". Under "PHARMACEUTICALS LLC" is a thin line, and above the letter "X" in "CURRAX" are two stacked, overlapping diamond shapes.
| Status Date | Action Taken |
|---|---|
| 26th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 26th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
| 21st Jun 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 19th Jun 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 16th Jun 2022 | EXAMINER'S AMENDMENT ENTERED |
| 15th Jun 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 15th Jun 2022 | EXAMINERS AMENDMENT E-MAILED |
| 15th Jun 2022 | SU-EXAMINER'S AMENDMENT WRITTEN |
| 24th May 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 24th May 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
